4008
D. C. Rogness, R. C. Larock / Tetrahedron Letters 50 (2009) 4003–4008
OTf
O
CsF, Cs2CO3
CO2Me
N
DME
90 °C, 24h
N
TMS
H
O
O
N
OMe
N
OMe
Cs
A
Scheme 2. Proposed mechanism.
4. (a) Tietze, L. F.; Bell, H. P.; Chandrasekhar, S. Angew. Chem., Int. Ed. 2003, 42,
3996–4028; (b) Zheng, L.; Xiang, J.; Dang, Q.; Guo, S.; Bai, X. J. Comb. Chem.
2005, 7, 813–815; (c) Meunier, B. Acc. Chem. Res. 2008, 41, 69–77; (d) Bajorath,
J. Mol. Diversity 2002, 5, 305–313.
5. Chen, Y.; Larock, R. C. In Modern Arylation Methods; Ackerman, J., Ed.; Wiley/
VCH: New York, 2009; pp 401–473.
6. (a) Liu, Z.; Larock, R. C. J. Am. Chem. Soc. 2006, 128, 13112–13122; (b)
Yoshida, H.; Shirakawa, E.; Honda, Y.; Hiyama, T. Angew. Chem., Int. Ed. 2002,
41, 3247–3249; (c) Tambar, U. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127,
5340–5341.
metrical, undergo smooth annulations. Single regioisomers have
been obtained in good yields for the unsymmetrical benzyne
precursors studied. This novel indole-indolone scaffold holds
great promise for biological activity. In addition, compounds 3j,
3l, 3m, and 3p–u are suitable for further elaboration via palla-
dium chemistry if a combinatorial library of these compounds
is desired.
7. (a) Zhao, J.; Larock, R. C. J. Org. Chem. 2007, 72, 583–588; (b) Zhao, J.; Larock, R.
C. Org. Lett. 2005, 7, 4273–4275.
Acknowledgments
8. Representative procedure (3i, Table 2, entry 9): An oven dried 6-dram vial
equipped with a stirrer bar was charged with 107.4 mg of 1i (0.50 mmol) and
223.8 mg of 2a (0.75 mmol), followed by 2.5 mL of dry DME. The mixture was
briefly stirred and 325.8 mg of dry Cs2CO3 and 341.8 mg of dry CsF were added
sequentially, followed by an additional 2.5 mL of DME, washing the sidewalls
of the vial. The vial was sealed and placed in an oil bath at 90 °C and allowed to
stir for 1 d. The resultant mixture was cooled and eluted through a plug of silica
gel with ethyl acetate and DCM. The filtrate was dried with anhydrous Na2CO3,
decanted, and evaporated. The residue was impregnated with silica gel and
purified by column chromatography (35:1–10:1 hexane/ethyl acetate),
affording 98.3 mg of the desired product 3i as a light orange solid; mp 203–
204 °C; 1H NMR (400 MHz, CDCl3) d 7.62 (d, J = 7.6 Hz, 1 H), 7.57 (s, 1 H), 7.50 (t,
J = 7.6 Hz, 1 H), 7.31–7.39 (m, 2 H), 7.26 (d, J = 8.0 Hz, 1H), 7.09 (t, J = 7.6 Hz, 1
H), 6.99 (s, 1 H); 13C NMR (100 MHz CDCl3) d 181.4, 145.3, 136.8, 135.8, 133.6,
132.5, 129.3, 128.5, 127.7, 125.5, 124.4, 124.4, 112.3, 111.4, 107.0; HRMS (EI):
calcd for C15H8ClNO 253.0294, found 253.0301.
We thank the National Institute of General Medical Sciences
(GM070620 and GM079593) and the National Institutes of Health
Kansas University Center of Excellence in Chemical Methodology
and Library Development (P50 GM069663) for their generous
financial support. We also thank Dr. Feng Shi for his help in the
preparation of some of the aryne precursors.
References and notes
1. Gil, C.; Brase, S. J. Comb. Chem. 2009, 11, 175–197.
2. Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893–930.
3. (a) Smith, G.; Glaser, M.; Perumal, M.; Nguyen, Q. D.; Shan, B.; Arstad, E.;
Aboagye, E. O. J. Med. Chem. 2008, 51, 8057–8067; (b) Manoury, P.; Binet, J.;
Obitz, D.; Defosse, G.; Dewitte, E.; Veronique, C. Indolone derivatives, their
preparation and their application in therapy. U.S. Patent 5,010,079, April 23,
1991.; (c) Konkel, M.; Packiarajan, M.; Chen, H. Aminoalkylphenyl indolone
derivatives. PCT Int. Appl. WO2006083538, 2006.
9. (a) Liu, Z.; Shi, F.; Martinez, P. D. G.; Raminelli, C.; Larock, R. C. J. Org. Chem.
2008, 73, 219–226; (b) Blackburn, T.; Romtohul, Y. K. Synlett 2008, 1159–1164;
(c) Jayanth, T. T.; Cheng, C. H. Angew. Chem., Int. Ed. 2007, 46, 5921–5924.
10. Waldo, J. P.; Zhang, X.; Shi, F.; Larock, R. C. J. Org. Chem. 2008, 73, 6679–
6685.